MA28340A1 - Derives de l'acide 7- amino-4- quinolone-3-carboxylique substitues par un groupe cycloalkyle, methode pour leur production et leur utilisation en tant que medicaments - Google Patents

Derives de l'acide 7- amino-4- quinolone-3-carboxylique substitues par un groupe cycloalkyle, methode pour leur production et leur utilisation en tant que medicaments

Info

Publication number
MA28340A1
MA28340A1 MA29219A MA29219A MA28340A1 MA 28340 A1 MA28340 A1 MA 28340A1 MA 29219 A MA29219 A MA 29219A MA 29219 A MA29219 A MA 29219A MA 28340 A1 MA28340 A1 MA 28340A1
Authority
MA
Morocco
Prior art keywords
quinolone
medicaments
amino
carboxylic acid
acid derivatives
Prior art date
Application number
MA29219A
Other languages
English (en)
Inventor
Elisabeth Defossa
Dieter Kadereit
Thomas Klabunde
Dieter Schmoll
Andreas Herling
Karl-Ulrich Wendt
Sven Ruf
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of MA28340A1 publication Critical patent/MA28340A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
MA29219A 2004-01-31 2006-07-28 Derives de l'acide 7- amino-4- quinolone-3-carboxylique substitues par un groupe cycloalkyle, methode pour leur production et leur utilisation en tant que medicaments MA28340A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004004971A DE102004004971B3 (de) 2004-01-31 2004-01-31 Cycloalkyl substituierte 7-Amino-4-chinolon-3-carbonsäure-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arnzeimittel

Publications (1)

Publication Number Publication Date
MA28340A1 true MA28340A1 (fr) 2006-12-01

Family

ID=34813070

Family Applications (1)

Application Number Title Priority Date Filing Date
MA29219A MA28340A1 (fr) 2004-01-31 2006-07-28 Derives de l'acide 7- amino-4- quinolone-3-carboxylique substitues par un groupe cycloalkyle, methode pour leur production et leur utilisation en tant que medicaments

Country Status (15)

Country Link
EP (1) EP1713804B1 (fr)
JP (1) JP4838730B2 (fr)
KR (1) KR20060132672A (fr)
CN (1) CN1910182A (fr)
AT (1) ATE389654T1 (fr)
AU (1) AU2005209368A1 (fr)
BR (1) BRPI0507321A (fr)
CA (1) CA2554527A1 (fr)
DE (2) DE102004004971B3 (fr)
IL (1) IL176915A0 (fr)
MA (1) MA28340A1 (fr)
MX (1) MXPA06007954A (fr)
NO (1) NO20063859L (fr)
RU (1) RU2006131307A (fr)
WO (1) WO2005073231A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
CA2666219C (fr) 2006-10-16 2017-02-07 Bionomics Limited Nouveaux composes anxiolytiques
US10954231B2 (en) 2006-10-16 2021-03-23 Bionomics Limited Anxiolytic compounds
EP2582709B1 (fr) 2010-06-18 2018-01-24 Sanofi Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases
WO2012116415A1 (fr) 2011-03-02 2012-09-07 Bionomics Limited Nouvelles petites molécules en tant que produits thérapeutiques
WO2012120058A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés d'oxathiazine substitués par des groupes benzyle ou hétérométhylène, leur procédé de production, leur utilisation comme médicament ainsi que produits pharmaceutiques les contenant et leur utilisation
US8871758B2 (en) 2011-03-08 2014-10-28 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
WO2012120057A1 (fr) 2011-03-08 2012-09-13 Sanofi Nouveaux dérivés phényl-oxathiazine substitués, procédé pour leur préparation, agent pharmaceutique contenant ces composés et leur utilisation
CA2835450C (fr) 2011-05-12 2020-05-12 Bionomics Limited Procedes pour la preparation de naphtyridines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE239477T1 (de) * 1995-08-02 2003-05-15 Darwin Discovery Ltd Chinolone und deren therapeutische verwendung
GB0205165D0 (en) * 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
DK1503759T3 (da) * 2002-05-14 2009-04-14 Univ California Substituerede quinoloncarboxylsyrer, deres derivater, virkningssted og anvendelser heraf

Also Published As

Publication number Publication date
EP1713804B1 (fr) 2008-03-19
MXPA06007954A (es) 2007-03-21
IL176915A0 (en) 2006-12-10
NO20063859L (no) 2006-08-29
CN1910182A (zh) 2007-02-07
ATE389654T1 (de) 2008-04-15
BRPI0507321A (pt) 2007-06-26
AU2005209368A1 (en) 2005-08-11
WO2005073231A1 (fr) 2005-08-11
JP2007519651A (ja) 2007-07-19
DE502005003310D1 (de) 2008-04-30
JP4838730B2 (ja) 2011-12-14
DE102004004971B3 (de) 2005-09-15
CA2554527A1 (fr) 2005-08-11
KR20060132672A (ko) 2006-12-21
EP1713804A1 (fr) 2006-10-25
RU2006131307A (ru) 2008-03-10

Similar Documents

Publication Publication Date Title
MA28340A1 (fr) Derives de l'acide 7- amino-4- quinolone-3-carboxylique substitues par un groupe cycloalkyle, methode pour leur production et leur utilisation en tant que medicaments
MA28339A1 (fr) Derives de l'acide 7- amino-4-quinolone-3-carboxylique substitues de maniere heterocyclique, methode pour leur production et leur utilisation en tant que medicaments
SE0301010D0 (sv) Novel compounds
EA201270666A1 (ru) Соединения и фармацевтические композиции для снижения уровня мочевой кислоты
TN2009000180A1 (en) NOVEL 1,4-BENZOTHIEPIN-l,1-DIOXIDE DERIVATIVES WHICH ARE SUBSTITUTED WITH BENZYL GROUPS, METHOD FOR PRODUCING DRUGS CONTAINING SAID COMPOUNDS AND USE THEREOF
TW200510333A (en) Benzimidazole compounds
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
CY1111327T1 (el) Υποκατεστημενα παραγωγα κυκλοεξυλοξεικου οξεος
ATE553095T1 (de) Neue imidazolderivate, deren herstellung und deren verwendung als intermediate zur herstellung von arzneimitteln und pestiziden
MA32505B1 (fr) 5-alcynyl-pyrimidines
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
DE602005020185D1 (de) Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4henprodukte für dieses verfahren
ATE438617T1 (de) Substituierte cyclohexyl-1,4-diamin-derivate
ATE437855T1 (de) (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit
MA27745A1 (fr) Derives d'acide benzoylureidopyridyl-piperidine et pyrrolidinecarboxylique substitues, methode de production de ceux-ci et utilisation de ceux-ci.
BRPI0408389A (pt) derivados de cromeno como agentes antiinflamatórios
MA27649A1 (fr) Derives d'acylphenyluree substitues par carbonylamino, methode de production et d'utilisation de ceux-ci.
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
BR0312586A (pt) Derivados de pirolidina como antagonistas e oxitocina
DE60307286D1 (de) Verfahren zur Herstellung von 2-Methyl Piperazine Derivaten.
MX2007010841A (es) 8-pirrolidinobenzimidazoles biciclicos sustituidos, un metodo para su produccion y su uso como medicamentos.
MXPA05008331A (es) Derivados de 3-(benzoilureido)-tiofeno sustituido, metodo para su produccion y uso de los mismos.
ATE473737T1 (de) Verwendung von 2,3-dehydronaringenin-derivaten zur behandlung von entzündungsprozessen und diese derivate enthaltende pharmazeutische zusammensetzung
TH85492A (th) สารประกอบซัลฟอกซิมีน-แมโครไซเคิลและเกลือของสารดังกล่าว, สารผสมทางเภสัชกรรมที่ประกอบรวมด้วยสารประกอบดังกล่าว, วิธีการเตรียมสารประกอบดังกล่าว และการใช้สารประกอบดังกล่าว